Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy.

Gallegos-Orozco JF, Werner KT, Rosati M, Byrne TJ, Balan V, Vargas HE, Rakela J.

Am J Gastroenterol. 2008 Aug;103(8):2161-2. doi: 10.1111/j.1572-0241.2008.01982_18.x. No abstract available.

PMID:
18796126
2.

[Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].

Yoshida H, Tateishi R, Omata M.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):511-4. Japanese. No abstract available.

PMID:
15359852
3.

[What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?].

Malfertheiner P.

Dtsch Med Wochenschr. 2002 Nov 29;127(48):2580. German. No abstract available.

PMID:
12457331
4.
6.

Hepatitis C: Should antiviral therapy be offered to elderly patients?

Floreani A.

Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):503-4. doi: 10.1038/nrgastro.2009.138.

PMID:
19713980
7.

Symposium on clinical aspects in hepatitis virus infection. 4. Topics of type C chronic liver disease.

Hayashi N.

Intern Med. 2001 Feb;40(2):180-1. Review. No abstract available.

8.

Data to guide the "test and treat era" of hepatitis C.

Ward JW, Rein DB, Smith BD.

Gastroenterology. 2012 Oct;143(4):887-9. doi: 10.1053/j.gastro.2012.08.027. No abstract available.

PMID:
22922026
9.

Necessities of interferon therapy in elderly patients with chronic hepatitis C.

Ikeda K, Arase Y, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Kumada H.

Am J Med. 2009 May;122(5):479-86. doi: 10.1016/j.amjmed.2008.09.045.

PMID:
19375558
10.

New developments in the antiviral treatment of hepatitis C.

de Bruijne J, Weegink CJ, Jansen PL, Reesink HW.

Vox Sang. 2009 Jul;97(1):1-12. doi: 10.1111/j.1423-0410.2009.01187.x. Review.

PMID:
19392783
11.

Screening for hepatocellular carcinoma in hepatitis B and C chronic carriers in Iran.

Fani A, Fani I, Eshratie B, Samadian P, Fani P, Gorishi Y.

Indian J Gastroenterol. 2007 Nov-Dec;26(6):297-8. No abstract available.

PMID:
18431018
12.

Hepatocellular carcinoma in Keio affiliated hospitals--diagnosis, treatment, and prognosis of this disease.

Saito H, Masuda T, Tada S, Ebinuma H, Yamagishi Y, Ojiro K, Inoue M, Hibi T.

Keio J Med. 2009 Sep;58(3):161-75. Review.

13.

Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients.

Hirakawa M, Ikeda K, Arase Y, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Kumada H.

Intern Med. 2008;47(19):1637-43.

14.

[Diagnosis and treatment of hepatitis C].

Thies P, Schmid RM, Geisler F.

MMW Fortschr Med. 2012 Nov 1;154(19):59-62. Review. German. No abstract available.

PMID:
23173289
15.

Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue.

Bruno R, Sacchi P, Filice C, Puoti M, Filice G.

J Acquir Immune Defic Syndr. 2002 Aug 15;30(5):535-6. No abstract available.

PMID:
12154346
16.

Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Tamura Y, Yamagiwa S, Aoki Y, Kurita S, Suda T, Ohkoshi S, Nomoto M, Aoyagi Y; Niigata Liver Disease Study Group..

Dig Dis Sci. 2009 Nov;54(11):2530-7. doi: 10.1007/s10620-008-0642-y.

PMID:
19093203
17.

Reply: To PMID 23564522.

Asahina Y, Tsuchiya K, Izumi N.

Hepatology. 2014 Aug;60(2):764. doi: 10.1002/hep.27066. No abstract available.

PMID:
24519221
18.

Could postinterferon treatment α-fetoprotein levels truly predict hepatocarcinogenesis?

Lo GH.

Hepatology. 2014 Aug;60(2):763. doi: 10.1002/hep.27065. No abstract available.

PMID:
24700196
19.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146.

20.

Hepatitis C: new therapeutic strategies needed for advanced disease.

Hofmann WP, Zeuzem S.

Nat Rev Gastroenterol Hepatol. 2009 Jun;6(6):325-7. doi: 10.1038/nrgastro.2009.63. No abstract available.

PMID:
19494822
Items per page

Supplemental Content

Support Center